New Lilly, BI diabetes med hits shelves; AstraZeneca launches online tool for docs;

> Eli Lilly ($LLY) and Boehringer Ingelheim's new Type 2 diabetes treatment Jardiance is now available in U.S. pharmacies. Release

> AstraZeneca ($AZN) has launched a new online tool in the U.S. to help medical professionals keep better up to date with their areas of study. More

> Valeant Canada has acquired Valeo Pharma's dermatology product portfolio and several specialty products. Release | Report

> Copenhagen has become the second city involved in Novo Nordisk's ($NVO) global "Cities Changing Diabetes" campaign. Story

> Mylan ($MYL) chose three kids with potentially life-threatening allergies to join NFL star Adrian Peterson to film an educational video about anaphylaxis. Release

And Finally... Merck ($MRK) has started the second year of a 5-year project to fight diabetes by supporting E-Learning in Africa. More

Suggested Articles

Only months removed from a gamechanging label expansion for Vascepa, Amarin is scrambling after a district judge invalidated the drug's key patents.

Move over, Roche. There’s a new small-cell lung cancer therapy on the scene, and it belongs to AstraZeneca.

Gilead CEO promised to make remdesivir affordable, shortly after the company backed off its request for orphan status amid a public backlash.